RDY - Dr. Reddy’s Laboratories Ltd ADR - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

RDY is currently covered by 1 analysts with an average price target of $81.57. This is a potential upside of $9.96 (13.91%) from yesterday's end of day stock price of $71.61.

Dr. Reddy’s Laboratories Ltd ADR's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of RDY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 291 days.

Highest price target for RDY is $80, Lowest price target is $80, average price target is $81.57.

Most recent stock forecast was given by BALAJI PRASAD from BARCLAYS on 29-Jan-2024. First documented stock forecast 02-Feb-2021.

Best performing analysts who are covering RDY - Dr. Reddy’s Laboratories Ltd ADR:

Balaji Prasad

Currently out of the existing stock ratings of RDY, 7 are a BUY (100%).

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$6.3 (8.55%)


2 months 21 days ago

6/8 (75%)

$9.96 (14.22%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RDY (Dr. Reddy’s Laboratories Ltd ADR) average time for price targets to be met?

On average it took 291 days on average for the stock forecasts to be realized with a an average price target met ratio 75

Which analyst has the current highest performing score on RDY (Dr. Reddy’s Laboratories Ltd ADR) with a proven track record?


Which analyst has the most public recommendations on RDY (Dr. Reddy’s Laboratories Ltd ADR)?

Balaji Prasad works at BARCLAYS and has 19 price targets and 10 ratings on RDY

Which analyst is the currently most bullish on RDY (Dr. Reddy’s Laboratories Ltd ADR)?

Balaji Prasad with highest potential upside - $6.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?